Quest Diagnostics Inc

DGX: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
?!&LOCK|$TTNLOCK|>>nC!@>

Quest Diagnostics Earnings: Outsize Revenue Growth Boosted by Acquisitions Should Linger Into 2025

Quest Diagnostics posted strong third-quarter results, with an assist from acquisitions that boosted quarterly volume growth to 5.5% year over year.

Sponsor Center